Exagen Inc. Reports Second Quarter 2026 Financial Results
Go back to Exagen Inc. Reports Second Quarter 2026 Financial Results| (NASDAQ: XGN) | Delayed: 8.17 -0.13 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.30 | 52 Week High | $0.46 | |||
| Open | $8.24 | 52 Week Low | $0.46 | |||
| Day High | $8.25 | P/E | N/A | |||
| Day Low | $7.98 | EPS | $0.00 | |||
| Volume | 362,566 | |||||
| (NASDAQ: XGN) | Delayed: 8.17 -0.13 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.30 | 52 Week High | $0.46 | |||
| Open | $8.24 | 52 Week Low | $0.46 | |||
| Day High | $8.25 | P/E | N/A | |||
| Day Low | $7.98 | EPS | $0.00 | |||
| Volume | 362,566 | |||||



